Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Top of the News-dtet
Simplifying At-Home Tests with AI
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
Whole-Genome Sequencing Can Improve Blood Transfusion Matches
From - Diagnostic Testing & Emerging Technologies
Antigen typing based on whole-genome sequencing (WGS) can enable more precise matching of blood transfusions, according to a study published online May 17 in…
Report Finds Genetic Tests and Their Reimbursement Increasingly Complex
From - Diagnostic Testing & Emerging Technologies
The health care technology company Concert Genetics (formerly NextGxDx; Nashville, Tenn.) recently released its third edition of…
Genetic Testing Emerges As New Trendy Workplace Benefit
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Screening Blood Donations for Zika, Costly With Low Yields
From - Diagnostic Testing & Emerging Technologies
Screening the entire U.S. blood supply for Zika virus may not be worth the $42 million price tag. Fifteen months of screening all…
CDC Receives Funding to Expand Laboratory Harmonization Efforts
From - Diagnostic Testing & Emerging Technologies
The FY 2018 omnibus appropriations bill, passed by Congress in late March, included a little noticed provision that could ultimately bring significant changes to the laboratory industry…
Profound Discrepancies Seen Between DTC Genetic Results, Confirmatory Testing
From - Diagnostic Testing & Emerging Technologies
Raw data from direct-to-consumer (DTC) genetic tests have an "alarmingly high" false-positive rate, according to a study published…
Diagnostic danger in the lab: Time to reform how we process orders
Recent report examining 10,000 claims to understand the key drivers of medical malpractice suits found 52 percent involved lab-related errors.
FDA Authorizes First Direct-to-Consumer Genetic Test for Cancer Risk
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Next-Gen Sequencing, AI Driving Investor Interest in Diagnostics Sector
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Testing Increasingly Adopted for Skin Cancer Diagnosis
From - Diagnostic Testing & Emerging Technologies
Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in…